| アブストラクト | OBJECTIVE: This study determined trends in hospital admission for diabetic ketoacidosis (DKA) in adults with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) from 1998 to 2013 in England. RESEARCH DESIGN AND METHODS: The study population included 23,246 adults with T1DM and 241,441 adults with T2DM from the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). All hospital admissions for DKA as the primary diagnosis from 1998 to 2013 were identified. Trends in hospital admission for DKA in incidence, length of hospital stay, 30-day all-cause readmission rate, and 30-day and 1-year all-cause mortality rates were determined using joinpoint regression, negative binomial regression, and logistic regression models. RESULTS: For T1DM, the incidence of hospital admission for DKA increased between 1998 and 2007 and remained static until 2013. The incidence in 2013 was higher than that in 1998 (incidence rate ratio 1.53 [95% CI 1.09-2.16]). For T2DM, the incidence increased 4.24% (2.82-5.69) annually between 1998 and 2013. The length of hospital stay decreased over time for both diabetes types (P </= 0.0004). Adults with T1DM were more likely to be discharged within 2 days compared with adults with T2DM (odds ratio [OR] 1.28 [1.07-1.53]). The 30-day readmission rate was higher in T1DM than in T2DM (OR 1.61 [1.04-2.50]) but remained unchanged for both diabetes types over time. Trends in 30-day and 1-year all-cause mortality rates were also stable, with no difference by diabetes type. CONCLUSIONS: In the previous two decades in England, hospitalization for DKA increased in adults with T1DM and in those with T2DM, and associated health care performance did not improve except decreased length of hospital stay. |
|---|
| ジャーナル名 | Diabetes care |
|---|
| 投稿日 | 2018/2/2 |
|---|
| 投稿者 | Zhong, Victor W; Juhaeri, Juhaeri; Mayer-Davis, Elizabeth J |
|---|
| 組織名 | Department of Nutrition, Gillings School of Global Public Health, University of;North Carolina, Chapel Hill, NC.;Department of Preventive Medicine, Northwestern University Feinberg School of;Medicine, Chicago, IL.;Global Pharmacovigilance and Epidemiology, Sanofi US, Bridgewater, NJ.;North Carolina, Chapel Hill, NC mayerdav@email.unc.edu.;Department of Medicine, School of Medicine, University of North Carolina, Chapel;Hill, NC. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/29386248/ |
|---|
